23andMe Shares Fall 14% On CFO Steven Schoch's Departure [MarketWatch]
23andMe Holding Co. (ME)
Company Research
Source: MarketWatch
is stepping down and will be succeeded in an interim capacity by Joseph Selsavage. Mr. Schoch delivered his letter of resignation to the company on Monday, and he will no longer fill the role as finance chief as of Sept. 1, the company said in a Friday filing with the U.S. Securities and Exchange Commission. At that time, Mr. Selsavage will assume the position of interim chief financial and accounting officer. Mr. Schoch will remain employed through Sept. 30 to help assist in the transition, the company said. His resignation is not the result of any dispute or disagreement with the company, 23andMe said. The company plans to conduct an executive search for a permanent finance chief. Mr. Selsavage is CFO of Lemonaid Health Inc., which was acquired by the 23andMe Holding last year. Shares of 23andMe were trading 46% lower for the year. Write to Kathryn Hardison at kathryn.hardison@wsj.com
Show less
Read more
Impact Snapshot
Event Time:
ME
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ME alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ME alerts
High impacting 23andMe Holding Co. news events
Weekly update
A roundup of the hottest topics
ME
News
- 23andMe announces CEO’s intention to pursue a potential take-privateGlobeNewswire
- Can 23andMe Holding (NASDAQ:ME) Afford To Invest In Growth? [Yahoo! Finance]Yahoo! Finance
- 23andMe Holding Co. (NASDAQ: ME) had its price target lowered by analysts at Citigroup Inc. from $0.85 to $0.47. They now have a "neutral" rating on the stock.MarketBeat
- 23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]Yahoo! Finance
- 23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024GlobeNewswire
ME
Sec Filings
- 4/19/24 - Form 4
- 4/18/24 - Form 8-K
- 4/17/24 - Form SC
- ME's page on the SEC website